POSTER SESSION I Monday, February 28, 2005   —  9:30 AM - 12:00 Noon Convention Center, Exhibit Hall B GYNECOLOGIC PATHOLOGY 108 Immunoprofile of Endocervical and Endometrial Stromal Cells and Its Potential Application in Localization of Tumor Involvement (824) JE Barroeta, TL Pasha, G Acs, PJ Zhang - University of Pennsylvania Medical Center, Philadelphia, PA 109 HER-2/neu Gene Amplification in Paget's Disease of the Nipple and Extramammary Site: A Chromogenic In Situ Hybridization (CISH) Study (826) MK Bianco, MA Vasef - University of Iowa Hospitals and Clinics, Iowa City, IA 110 Molecular Genotyping and Microsatellite Instability in Mixed Uterine Serous Papillary and Endometrioid Adenocarcinomas (836) BZ Clark, JL Hunt, D Lomago, DJ Dabbs - University of Pittsburgh, Pittsburgh, PA 111 Frequency of Allelic Loss of Tumor Suppressor Genes in Uterine Smooth Muscle Tumors (846) NN Esposito, JL Hunt, A Bakker, MW Jones - University of Pittsburgh, Pittsburgh, PA; Magee-Womens Hospital of UPMC, Pittsburgh, PA 112 Frequency of Extrauterine Disease in Serous Carcinoma and Serous Endometrial Intraepithelial Carcinoma (EIC) Confined to an Endometrial Polyp (860) D Hileeto, O Fadare, W Zheng - Yale University School of Medicine, New Haven, CT 113 Diagnostic and Pathogenetic Significances of Apoptosis and Proliferating Activity (PA) in the Villous Stroma of Complete Hydatidiform Moles (CHMs) (874) MJ Kim, HI Lee, S-Y Jun, JY Ro, K-R Kim - University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea; Hallym University, Pyongchon Sacred Heart Hospital, Anyang, Korea 114 Expression of Ezrin Is an Indenpendent Prognostic Factor in Human Ovarian Carcinoma (877) M Köbel, E Knolle, S Hauptmann - Martin-Luther-University, Halle, Germany 115 Extragastrointestinal Stromal Tumors (EGISTs) Presenting as Vulvovaginal/Rectovaginal Septal Masses: A Diagnostic Pitfall (885) MM Lam, CL Corless, JR Goldblum, MC Heinrich, E Downs-Kelly, BP Rubin - University of Washington Medical Center, Seattle, WA; Oregon Health and Science University, Portland, OR; Cleveland Clinic Foundation, Cleveland, OH 116 In Search of New Molecular Markers in the Diagnosis of Endometrial Cancer (890) EML Li Ning, RSJ Ricketts, MA Palau, C Otis, DD Roberts, MJ Merino - NCI/ NIH, Bethesda, MD; Tufts University School of Medicine, Springfield, MA 117 Utility of p16INK4A , CEA, Ki67, p53 and ER/PR in the Differential Diagnosis of Benign, Premalignant and Malignant Glandular Lesions of the Uterine Cervix (891) J Liang, K Mittal, J Wei, H Yee, S Goswami, L Chiriboga, P Shukla - New York Univeristy Medical Center, New York, NY 118 p16 Highlights Significant Cervical Glandular Dysplasia (905) S Mehrotra, A Paintal, N Siddiqui, SE Pambuccian, S Setty, A Kajdacsy-Balla - University of Illinois at Chicago, Chicago, IL 119 Late (< 10 Yrs) Recurrences of Ovarian Cancer: A Study of 896 Cases of Macrocopically Resectable Ovarian Surface Epithelial Carcinoma (914) QB Nakonechny, J Santos, K Swenerton, CB Gilks - University of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada 120 Analysis of Teratomas for Isochromosome 12p: Evidence Supporting a Dual Pathway for Teratomatous Elements in the Ovary (925) CK Poulos, L Cheng, K Ma, TM Ulbright - Indiana University School of Medicine, Indianapolis, IN 121 Expression of 14-3-3 s Protein Is Independent of Expression of p53 and p16 in Vulvar Intraepithelial Neoplasia and Invasive Squamous Cell Carcinoma (926) A Powers, WR Hart, B Yang - Cleveland Clinic Foundation, Cleveland, OH 122 Immunohistochemical Staining for p16INK4A and p53 in Squamous Cell Carcinomas of the Vulva (942) M Santos, LM Puig-Tintoré, B Mellado, A Torné, B Lloveras, J Klaustermeier, E Campo, J Ordi - IDIBAPS-Hospital Clínic. University of Barcelona. School of Medicine, Barcelona, Spain; L'Hospitalet del Llobregat, Spain 123 BRAF, RAS and RET Mutations in Malignant Struma Ovarii: A Comparative Study with Benign Struma Ovarii (945) JF Schmidt, M Heinrich, V Derr, CL Corless, JA Fletcher, V Nosé - Brigham & Women's Hospital, Harvard Medical School, Boston, MA; Oregon Health & Sciences University, Portland, OR 124 Over-Expression of the Human Septin SEPT9 in Borderline and Malignant Ovarian Epithelial Tumours (946) M Scott, SEH Russell, PA Hall - Queen's University Belfast, Belfast, Northern Ireland, United Kingdom 125 Retrograde Transtubal Spread in Extra-Uterine Metastasis of Uterine Serous Carcinoma (950) MJ Snyder, RC Bentley, C Lutman, SJ Robboy - Duke University Medical Center, Durham, NC 126 Beta-Catenin Expression in Endometrial Carcinoma (EC) in Patients with Estrogen Stimulation Secondary to Ovarian Hyperthecosis or Tamoxifen Therapy (959) J Turbiner, C Sanchez, S Dahiya, G Moreno, D Hardisson, J Palacios, E Oliva - Massachusetts General Hospital, Boston, MA; Centro Nacional de Investigaciones Oncologicas, Madrid, Spain; Hospital Universitario La Paz, Madrid, Spain 127 The Kallikrein Proteins: New Potential Biomarkers for Ovarian Cancer (972) GM Yousef, D Katsaros, EP Diamandis - Mount Sinai Hospital, Toronto, ON, Canada; University of Turin, Turin, Italy 128 Vulvar Seborrheic Keratosis, Is It Indeed Related to HPV Infection? (973) H Zhang, K Storthz, A Malpica - UT M.D. Anderson Cancer Center, Houston, TX; UT Dental Branch, Houston, TX 129 Examination of Phosphatidylinositol 3-Kinase (PI3K) and Its Associated Signaling Proteins in Endometrial Carcinoma (EC) (975) CC Zhu, JJ Wei, L Chiriboga, S Goswami, K Mittal - New York University School of Medicine, New York, NY